Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9BZH6: Variant p.Pro537Leu

WD repeat-containing protein 11
Gene: WDR11
Feedback?
Variant information Variant position: help 537 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Proline (P) to Leucine (L) at position 537 (P537L, p.Pro537Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In HH14; mild phenotype; decreases capacity to shuttle from cilium to nucleus; decreases interaction with EMX1; no effect on GLI3 protein levels. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 537 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1224 The length of the canonical sequence.
Location on the sequence: help EVKGIEWTSLTSFLSFATST P NNMGLVRNELQLVDLPTGRS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         EVKGIEWTSLTSFLSFATSTPNNMGLVRNELQLVDLPTGRS

Mouse                         EVKGIEWTSLTSFLSFAASTPNNMGLVRNELQLVDLPTGRS

Zebrafish                     EVRGIEWISLTSFLSFATSVPNNLGLVRNELQHVDLRTGRC
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1224 WD repeat-containing protein 11



Literature citations
WDR11-mediated Hedgehog signalling defects underlie a new ciliopathy related to Kallmann syndrome.
Kim Y.J.; Osborn D.P.; Lee J.Y.; Araki M.; Araki K.; Mohun T.; Kaensaekoski J.; Brandstack N.; Kim H.T.; Miralles F.; Kim C.H.; Brown N.A.; Kim H.G.; Martinez-Barbera J.P.; Ataliotis P.; Raivio T.; Layman L.C.; Kim S.H.;
EMBO Rep. 19:269-289(2018)
Cited for: FUNCTION; SUBCELLULAR LOCATION; INTERACTION WITH EMX1 AND GLI3; VARIANT HH14 LEU-537; CHARACTERIZATION OF VARIANTS HH14 TRP-395; THR-435; GLN-448; LEU-537; GLN-690 AND LEU-1150;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.